CRISPR-TB Trademark

Trademark Overview

On Friday, December 12, 2025, a trademark application was filed for CRISPR-TB with the United States Patent and Trademark Office. The USPTO has given the CRISPR-TB trademark a serial number of 99975307. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Tuesday, June 2, 2026. This trademark is owned by IGDX, Inc.. The CRISPR-TB trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Medical testing for diagnostic or treatment purposes
crispr-tb

General Information

Serial Number99975307
Word MarkCRISPR-TB
Filing DateFriday, December 12, 2025
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateTuesday, June 2, 2026
Registration Number0000000
Registration DateTuesday, June 23, 2026
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesMedical testing for diagnostic or treatment purposes
Pseudo MarkCRISPR TUBERCULOSIS
Pseudo MarkCRISPR TB

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, December 12, 2025
Primary Code044
First Use Anywhere DateWednesday, October 22, 2025
First Use In Commerce DateWednesday, October 22, 2025

Trademark Owner History

Party NameIGDX, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressHouston, TX 77040
US

Trademark Events

Event DateEvent Description
Friday, December 12, 2025NEW APPLICATION ENTERED
Friday, December 12, 2025APPLICATION FILING RECEIPT MAILED
Monday, April 6, 2026NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, April 16, 2026ASSIGNED TO EXAMINER
Thursday, April 16, 2026NON-FINAL ACTION WRITTEN
Thursday, April 16, 2026NON-FINAL ACTION E-MAILED
Thursday, April 16, 2026NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, May 12, 2026TEAS REQUEST TO DIVIDE RECEIVED
Tuesday, May 12, 2026TEAS AMENDMENT OF USE RECEIVED
Friday, May 15, 2026ASSIGNED TO LIE
Monday, May 18, 2026CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, May 12, 2026DIVISIONAL REQUEST RECEIVED
Monday, May 18, 2026DIVISIONAL PROCESSING COMPLETE
Wednesday, May 20, 2026CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, May 12, 2026USE AMENDMENT FILED
Tuesday, May 12, 2026AMENDMENT TO USE PROCESSING COMPLETE
Thursday, May 21, 2026USE AMENDMENT ACCEPTED
Saturday, May 23, 2026TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, May 23, 2026CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, May 23, 2026TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, May 26, 2026APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER

Related Keywords

crispr purposes treatment diagnostic testing medical